Kadri AltundaÄ,
MKA Breast Cancer Clinic, Ankara, Turkey
Shihori Tanabe,
National Institute of Health Sciences, Japan
Chi-Yu Gregory Lee, The University of British Columbia, Canada
Submit manuscript at Online Submission System or send as an e-mail attachment to the Editorial Office at info@primescholars.com
ICV Value: 56.17
The Research Journal of Oncology is a peer-reviewed, open access Journal dedicated to publish original research in the field of Oncology Research. The Journal publishes interventional as well as clinical studies dealing with oncology, This scholarly open access journal aims to publish the most complete and reliable source of information on discoveries and current developments in the mode of original articles, review articles, case reports, short communications, etc. in the field and provide free access through online without any restrictions or any other subscriptions to researchers worldwide.
In addition to research articles, the Journal also publishes high quality Perspectives, Commentaries, and Reviews aimed at synthesizing new hypotheses, and improving diagnostic and treatment strategies.
Authors are invited to provide their valuable contributions to the field, All the articles are peer-reviewed and published under the guidance of our Editorial Board members.
To submit manuscript use Online Submission System or can also send your work as an e-mail attachment to the Editorial Office at manuscripts@primescholars.com
The Research Journal of Oncology places special focus on research involving early cancer detection, cancer genetics, tumor markers, and mechanisms of cell death. Studies discussing cancer treatment strategies and associated aspects such as: chemotherapy, radiotherapy, immunotherapy, anesthesia for cancer surgery, allogenic stem-cell transplantation, down staging of advanced tumors, minimally invasive surgical techniques, nonsurgical tumor ablation, and cancer vaccines are welcome.
The journal welcomes submissions concerning cellular and molecular biology, epidemiology, genetics, and clinical trials.
Fast Editorial Execution and Review Process (FEE-Review Process):
Research Journal of Oncology is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.
Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.
The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.
Articles published in Research Journal of Oncology have been cited by esteemed scholars and scientists all around the world. Research Journal of Oncology has got h-index 4 , which means every article in Research Journal of Oncology has got 4 average citations.